Identifying Barriers to Developing Expertise in Hidradenitis Suppurativa.

Casey Schukow, Clare Townsend, Nicole Jess, Steven Daveluy

Abstract read

In one paragraph

Article in The Journal of clinical and aesthetic dermatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Casey SchukowDr. Schukow is with the Department of Pathology at Corewell Health in Royal Oak, Michigan.

Clare TownsendDr. Townsend is with the Boston Medical Center in Boston, Massachusetts.

Nicole JessMs. Jess is with Michigan State University in East Lansing, Michigan.

Steven DaveluyDr. Daveluy is with the Department of Dermatology at Wayne State University in Detroit, Michigan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disorder of hair-bearing intertriginous areas with a profound impact on quality of life. Objective: We sought to determine what barriers to treatment exist among both HS experts and non-experts. Methods: An IRB-approved, anonymous, voluntary survey was distributed to dermatologists through the HS Foundation listserv from June to September 2021. Results: Eighty-eight total responses were collected from 49 (55.7%) experts and 39 (44.3%) non-experts. Statistically significant differences were found in the comfort level of treating moderate ( Limitations: We were unable to calculate response rate since listserv survey recipients were encouraged to share the survey through their personal networks. Conclusion: This data demonstrates statistically significant differences in levels of comfort and interest between experts and non-experts in treating moderate to severe disease, as well as differences in medical therapies utilized. Furthermore, multiple barriers to expertise were identified by both experts and non-experts.

Indexed as

Dermatologyexpertisehidradenitis suppurativamedicinesurgerytraining

Identifiers

PMID37720198

PMCPMC10503938

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.